
Join to view full profile
460 W 10th AveColumbus, OH 43210
Phone+1 614-293-0341
Fax+1 614-293-6037
Dr. Rahman is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Hematology and Medical Oncology, 2019 - 2022
Cleveland Clinic FoundationResidency, Internal Medicine, 2016 - 2019
Government Medical College SrinagarClass of 2015
Certifications & Licensure
OH State Medical License 2022 - 2028
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Dual targeting of DHODH and SLC29A1 overcomes metabolic resistance and enhances antitumor immune responses in PDAC.Rajgopal Govindarajan, Shivam Vij, Arnav Joshi, Sandip M Vibhute, Chengyu Gao
Molecular Cancer Therapeutics. 2026-10-29 - Advances in KRAS-Targeted Therapies for Pancreatic Cancer.Supriya Peshin, Afra Zahid, Ehab Takrori, Zahra Hamedi, Shafia Rahman
Cancers. 2026-09-14 - Genomic landscape and clinical characteristics of ERBB2/HER2-mutated colorectal cancers.Muhammed Dogukan Aksu, Paola Zinser Peniche, Doga Kahramangil Baytar, Bhaghyasree Jambunathan, Yu Jen Alexander Jan
The Oncologist. 2026-08-06
Authored Content
- Is Chemo-Immunotherapy Combination the New Standard of Care for Biliary Tract Cancers?January 2022
Press Mentions
FDA Approves Rasonque for Advanced Pancreatic Cancer Patients in the USAugust 29th, 2026
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: